Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives that have the potential to transform the standard of care and save or improve patients’ lives. Cidara also leverages the novel Cloudbreak™ platform to develop antibody-drug conjugates for treatment of serious viral and Gram-negative bacterial infections.

Cidara Therapeutics Inc

Pharmaceutical

United States of America

The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The pharmaceutical industry is developing at an unusually rapid pace. The market for pharmaceuticals is growing persistently, and expenses for drugs will amount to $1.5 trillion globally by 2021. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. Investments in biopharmaceutical innovation are driving contributions to the American economy and solidifying America’s role as a leader in medical innovation. The pharmaceuticals sector is forecasted to grow faster than any other market in the next five years with an emphasis on R&D.

Irvine

California

San Diego

51-200 Employees

Cidara's Cloudbreak antiviral platform is a fundamentally new approach in the fight against life-threatening infectious disease.

Careers and Openings at Cidara Therapeutics Inc